IP Library › Assignment 047894/0947
Patent Assignment
Reel/Frame 047894/0947

Release of Security Interest

Recorded: 2019-01-03 Pages: 6
Assignors
DEERFIELD PARTNERS, L.P.
Executed: 2018-12-31
Assignee
POZEN INC.
400 ALEXANDER PARK DRIVE, PRINCETON, NEW JERSEY, 08540
Covered Properties (14)
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 6,926,907 →
Application: 10/158,216 →
Publication: US 2003/0069255
Multilayer Dosage Forms Containing Nsaids and Triptans
Patent: 7,332,183 →
Application: 10/741,592 →
Publication: US 2004/0180089
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 8,206,741 →
Application: 11/129,320 →
Publication: US 2005/0249811
Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof
Patent: 9,220,698 →
Application: 12/553,107 →
Publication: US 2010/0062064
Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole
Application: 12/553,804 →
Publication: US 2010/0172983
Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
Patent: 8,945,621 →
Application: 12/822,612 →
Publication: US 2010/0330179
Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs
Patent: 8,557,285 →
Application: 13/215,855 →
Publication: US 2012/0064156
Pharmaceutical Compositions For The Coordinated Delivery Of NSAIDs
Application: 13/475,446 →
Publication: US 2013/0078305
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 8,852,636 →
Application: 14/045,156 →
Publication: US 2014/0141080
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 8,865,190 →
Application: 14/231,971 →
Publication: US 2014/0212572
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 8,858,996 →
Application: 14/244,471 →
Publication: US 2014/0212489
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 9,161,920 →
Application: 14/515,627 →
Publication: US 2015/0125524
Method for Treating a Patient at Risk for Developing an Nsaid-Associated Ulcer
Application: 14/593,212 →
Publication: US 2015/0202193
Pharmaceutical Compositions for the Coordinated Delivery of Nsaids
Patent: 9,198,888 →
Application: 14/753,195 →
Publication: US 2015/0297543
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2010
From: POZEN INC.
To: ASTRAZENECA UK LIMITED
Reel/Frame 023987/0313 →
Assignment of Assignor's Interest Feb 24, 2010
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 023987/0303 →
Assignment of Assignor's Interest Feb 24, 2010
From: ORLEMANS, EVERARDUS; PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 023987/0300 →
Assignment of Assignor's Interest Feb 24, 2010
From: AULT, BRIAN; SOSTEK, MARK
To: ASTRAZENECA R&D WILMINGTON
Reel/Frame 023987/0290 →
Assignment of Assignor's Interest Feb 24, 2010
From: ASTRAZENECA UK LIMITED
To: POZEN INC.
Reel/Frame 023987/0309 →
Assignment of Assignor's Interest Oct 7, 2010
From: PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 025110/0242 →
Corrective Assignment to Correct the Receiving Party Name Should Be Astrazeneca Pharmaceuticals Lp Previously Recorded on Reel 023987 Frame 0290. Assignor(S) Hereby Confirms the Receiving Party Name Should Be Changed from Astrazeneca R&D Wilmington to Astrazeneca Pharmaceuticals Lp. Feb 16, 2011
From: AULT, BRIAN; SOSTEK, MARK
To: ASTRAZENECA PHARMACEUTICALS LP
Reel/Frame 025810/0644 →
Assignment of Assignor's Interest Aug 28, 2012
From: ORLEMANS, EVERARDUS; PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 028860/0880 →
Assignment of Assignor's Interest Aug 28, 2012
From: AULT, BRIAN; HWANG, CLARA; SOSTEK, MARK
To: ASTRAZENECA PLP
Reel/Frame 028860/0759 →
Assignment of Assignor's Interest Aug 28, 2012
From: ASTRAZENECA AB
To: ASTRAZENECA AB; POZEN INC.
Reel/Frame 028861/0066 →
Assignment of Assignor's Interest Aug 28, 2012
From: POZEN INC.
To: ASTRAZENECA AB
Reel/Frame 028861/0035 →
Assignment of Assignor's Interest Aug 28, 2012
From: ASTRAZENECA UK LIMITED
To: ASTRAZENECA AB
Reel/Frame 028860/0990 →
Assignment of Assignor's Interest Aug 28, 2012
From: ASTRAZENECA PHARMACEUTICALS LP
To: ASTRAZENECA UK LIMITED
Reel/Frame 028860/0940 →
Assignment of Assignor's Interest Oct 11, 2012
From: ASTRAZENECA UK LIMITED; POZEN INC.
To: ASTRAZENECA AB
Reel/Frame 029113/0459 →
Assignment of Assignor's Interest Dec 12, 2013
From: ASTRAZENECA AB
To: HORIZON PHARMA USA, INC.
Reel/Frame 031770/0398 →
Assignment of Assignor's Interest Dec 12, 2013
From: ASTRAZENECA AB
To: HORIZON PHARMA USA, INC.
Reel/Frame 031770/0611 →
Patent Security Agreement Nov 10, 2014
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 034197/0415 →
Security Interest May 7, 2015
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 035591/0028 →
Release of Security Interest May 7, 2015
From: CITIBANK, N.A.
To: HORIZON PHARMA USA, INC.
Reel/Frame 035590/0194 →
Corrective Assignment to Correct the Incorrect Execution Date Previously Recorded at Reel: 035591 Frame: 0028. Assignor(S) Hereby Confirms the Security Interest. Aug 6, 2015
From: HORIZON PHARMA USA, INC.
To: CITIBANK, N.A.
Reel/Frame 036303/0708 →
Security Interest Apr 21, 2016
From: POZEN INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.; DEERFIELD PARTNERS, L.P.
Reel/Frame 038342/0089 →
Assignment of Assignor's Interest Jul 24, 2018
From: POZEN, INC.
To: GENUS LIFESCIENCES, INC.
Reel/Frame 046445/0466 →
Assignment of Assignor's Interest Jul 26, 2018
From: HORIZON PHARMA USA, INC.
To: HORIZON MEDICINES LLC
Reel/Frame 046465/0336 →
Release of Security Interest Aug 6, 2018
From: DEERFIELD PRIVATE DESIGN FUND III, L.P.; DEERFIELD PARTNERS, L.P.; DEERFIELD INTERNATIONAL MASTER FUND, L.P.
To: POZEN, INC.
Reel/Frame 046562/0778 →
Security Interest Aug 24, 2018
From: POZEN INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS ADMINISTRATIVE AGENT
Reel/Frame 046697/0526 →